Treatment algorithm for COVID-19: a multidisciplinary point of view

F Galluccio, T Ergonenc, A Garcia Martos… - Clinical …, 2020 - Springer
Abstract The novel coronavirus (Sars-CoV-2) pandemic has spread rapidly, from December
to the end of March, to 185 countries, and there have been over 3,000,000 cases identified …

Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …

[HTML][HTML] Current treatment in COVID-19 disease: a rapid review

M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
The world has faced the most challenging pandemic of the modern era, that of severe acute
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

Efficacy of different types of therapy for COVID-19: A comprehensive review

A Starshinova, A Malkova, U Zinchenko, D Kudlay… - Life, 2021 - mdpi.com
A new coronavirus disease (COVID-19) has already affected millions of people in 213
countries. The possibilities of treatment have been reviewed in recent publications but there …

The rheumatology drugs for COVID-19 management: which and when?

F Atzeni, IF Masala, J Rodríguez-Carrio… - Journal of clinical …, 2021 - mdpi.com
Introduction: While waiting for the development of specific antiviral therapies and vaccines to
effectively neutralize the SARS-CoV2, a relevant therapeutic strategy is to counteract the …

Current understanding of COVID-19 clinical course and investigational treatments

RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …

COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients

S Bellino - Annals of medicine, 2022 - Taylor & Francis
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …

The cytokine storm in COVID-19: the strongest link to morbidity and mortality in the current epidemic

M Basheer, E Saad, N Assy - COVID, 2022 - mdpi.com
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. The clinical
presentations of the SARS-CoV-2 infection are widely variable and treatment strategies for …

Review on therapeutic targets for COVID-19: insights from cytokine storm

ML de Mélo Silva Júnior, LMA de Souza… - Postgraduate …, 2021 - academic.oup.com
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
caused the greatest pandemic of our century. Many of the deaths related to it are due to a …